In patients with acute coronary syndrome, the ROC analysis for differentiating NSTEMI from STEMI found that subfatin had 94% sensitivity and 41% specificity, whereas troponin had 65% sensitivity and 88% specificity (Table 3 and Figure 2). Here, METRNL is linked to acute coronary syndrome.